Skip to main content

RETRACTED CHAPTER: Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease

  • Chapter
  • First Online:
Progress in Nanomedicine in Neurologic Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hari Shanker Sharma .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Buzoianu, A.D. et al. (2023). RETRACTED CHAPTER: Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease. In: Sharma, H.S., Sharma, A. (eds) Progress in Nanomedicine in Neurologic Diseases. Advances in Neurobiology, vol 32. Springer, Cham. https://doi.org/10.1007/978-3-031-32997-5_2

Download citation

Publish with us

Policies and ethics